European Healthtech startup funding raised during H1 2016.
In H1 2016, 164 European Healthtech companies raised a combined €1.2B across 172 funding rounds, up 130.3% versus H1 2015. UK led by capital raised, and Bayern Kapital was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Growth/Late | Mar 2016 | €111M |
| MindMaze | Growth/Late | Jan 2016 | €92M |
| F2G | Growth/Late | May 2016 | €55M |
| Brillen.de | Growth/Late |
18 exits · €1.9B disclosed.
| Arcam | Acquisition | Jan 2016 | €636M |
| Valtech Cardio | Acquisition | Mar 2016 | €628M |
| EngMab | Acquisition | Apr 2016 | €545M |
| Creo Medical | IPO | Jun 2016 | €74M |
| Jun 2016 |
| €45M |
| AC Immune | Series D+ | Apr 2016 | €40M |
| CRISPR Therapeutics | Series B | May 2016 | €35M |
| MedDay | Series B | Mar 2016 | €34M |
| Impulse Dynamics | Growth/Late | Apr 2016 | €30M |
| G-Therapeutics | Series A | Mar 2016 | €26M |
| STAT-Diagnostica | Series C | Mar 2016 | €25M |
| EarlySense | Series D+ | May 2016 | €23M |
| Allecra Therapeutics | Series B | May 2016 | €22M |
| apotea.se | Growth/Late | Apr 2016 | €22M |
| Cambridge Epigenetix | Series B | Feb 2016 | €19M |
| Cambridge Medical Robotics | Series A | Jun 2016 | €18M |
